10.74
0.31 (2.97%)
| Previous Close | 10.43 |
| Open | 10.45 |
| Volume | 359,828 |
| Avg. Volume (3M) | 463,680 |
| Market Cap | 544,414,720 |
| Price / Earnings (Forward) | 20.16 |
| Price / Sales | 0.510 |
| Price / Book | 0.940 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Profit Margin | -13.43% |
| Operating Margin (TTM) | 6.12% |
| Diluted EPS (TTM) | -2.77 |
| Quarterly Revenue Growth (YOY) | -1.00% |
| Quarterly Earnings Growth (YOY) | 8,800.00% |
| Total Debt/Equity (MRQ) | 94.85% |
| Current Ratio (MRQ) | 1.49 |
| Operating Cash Flow (TTM) | 51.80 M |
| Levered Free Cash Flow (TTM) | 54.45 M |
| Return on Assets (TTM) | 2.31% |
| Return on Equity (TTM) | -21.36% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Enhabit, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | 1.5 |
| Price Volatility | -5.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | 0.20 |
|
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 3.19% |
| % Held by Institutions | 99.89% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| 8 Knots Management, Llc | 30 Sep 2025 | 4,218,846 |
| Arex Capital Management, Lp | 30 Sep 2025 | 2,489,046 |
| Jana Partners Management, Lp | 30 Sep 2025 | 2,137,145 |
| Paradice Investment Management Llc | 30 Sep 2025 | 1,736,964 |
| Kent Lake Pr Llc | 30 Sep 2025 | 1,079,607 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 14.00 (Oppenheimer, 30.35%) | Buy |
| Median | 12.00 (11.73%) | |
| Low | 12.00 (UBS, 11.73%) | Buy |
| 12.00 (TD Cowen, 11.73%) | Buy | |
| Average | 12.67 (17.97%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 10.63 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Oppenheimer | 22 Jan 2026 | 14.00 (30.35%) | Buy | 10.74 |
| TD Cowen | 13 Jan 2026 | 12.00 (11.73%) | Buy | 10.95 |
| UBS | 08 Jan 2026 | 12.00 (11.73%) | Buy | 10.19 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Dec 2025 | Announcement | Enhabit Announces Participation in Bank of America Home Care Conference 2025 |
| 05 Nov 2025 | Announcement | Enhabit Reports Third Quarter 2025 Financial Results |
| 28 Oct 2025 | Announcement | Enhabit Announces Participation in UBS Global Healthcare Conference 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |